Aberrant miRNA expression response to UV irradiation in human liver cancer cells

Liang,Gaofeng; Li,Guangda; Wang,Yanyan; Lei,Wanjun; Xiao,Zhongdang

doi:10.3892/mmr.2014.1901

Aberrant miRNA expression response to UV irradiation in human liver cancer cells

Authors:
- Gaofeng Liang
- Guangda Li
- Yanyan Wang
- Wanjun Lei
- Zhongdang Xiao
View Affiliations

Affiliations: Department of Biomedical Engineering, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China, State Key Laboratory of Bioelectronics, Department of Biomedical Engineering, School of Biological Science & Medical Engineering, Southeast University, Nanjing, Jiangsu 210096, P.R. China
Published online on: January 15, 2014 https://doi.org/10.3892/mmr.2014.1901
Pages: 904-910

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

microRNAs (miRNAs) are small, highly conserved, non-coding RNAs that regulate gene expression at the post‑transcriptional level. The expression of these small RNA genes is tightly regulated during development, differentiation and apoptosis of normal cells, however, they are often deregulated in various types of cancer. miRNA expression is also affected by cellular stress, including radiation and chemotherapy. The present study monitored the expression levels of several miRNAs by using the stem-loop real-time polymerase chain reaction (PCR) in HepG2 cells following ultraviolet (UV) radiation. Our data demonstrated that UV irradiation is able to induce alterations in miRNA expression levels in HepG2 cells. Among them, miR-26a, miR-34a and miR-146a were significantly upregulated, while the expression of miR-21 was significantly downregulated. Bioinformatics analysis of these significantly regulated miRNAs was discussed. The results also indicated that miRNAs may be part of the innate response mechanism of the cells to radiation injury, which provides a rationale for miRNA replacement therapy by using specific miRNAs that may function as tumor suppressor genes in several types of cancer.

View Figures

View References

1	Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar
2	O’Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 435:839–843. 2005.PubMed/NCBI
3	Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY: miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007. View Article : Google Scholar : PubMed/NCBI
4	Qi LQ, Bart J, Tan LP, et al: Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer. 9:1632009. View Article : Google Scholar : PubMed/NCBI
5	Pineau P, Volinia S, McJunkin K, et al: miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA. 107:264–269. 2010. View Article : Google Scholar : PubMed/NCBI
6	Voorhoeve PM, Le Sage C, Schrier M, et al: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 124:1169–1181. 2006. View Article : Google Scholar
7	Liu AM, Poon RT and Luk JM: MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun. 394:623–627. 2010. View Article : Google Scholar : PubMed/NCBI
8	Yang Y, Chaerkady R, Beer MA, Mendell JT and Pandey A: Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics. 9:1374–1384. 2009. View Article : Google Scholar : PubMed/NCBI
9	Yamamichi N, Shimomura R, Inada KI, et al: Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res. 15:4009–4016. 2009. View Article : Google Scholar : PubMed/NCBI
10	Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
11	Gaur A, Jewell DA, Liang Y, et al: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67:2456–2468. 2007. View Article : Google Scholar : PubMed/NCBI
12	Lau NC, Lim LP, Weinstein EG and Bartel DP: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 294:858–862. 2001. View Article : Google Scholar : PubMed/NCBI
13	Ji JF, Shi J, Budhu A, et al: MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med. 361:1437–1447. 2009. View Article : Google Scholar : PubMed/NCBI
14	Szumiel I: Intrinsic radiation sensitivity: cellular signaling is the key. Radiat Res. 169:249–258. 2008. View Article : Google Scholar : PubMed/NCBI
15	An IS, An S, Kang SM, et al: Titrated extract of Centella asiatica provides a UVB protective effect by altering microRNA expression profiles in human dermal fibroblasts. Intl J Mol Med. 30:1194–1202. 2012.
16	Chen CF, Ridzon DA, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
17	Chaudhry MA: Real-time PCR analysis of micro-RNA expression in ionizing radiation-treated cells. Cancer Biother Radiopharm. 24:49–55. 2009. View Article : Google Scholar : PubMed/NCBI
18	Guo L, Huang ZX, Chen XW, et al: Differential expression profiles of microRNAs in NIH3T3 cells in response to UVB irradiation. Photochem Photobiol. 85:765–773. 2009. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(−Delta Delta C) method. Methods. 25:402–408. 2001.PubMed/NCBI
20	Alexiou P, Maragkakis M, Papadopoulos GL, Simmosis VA, Zhang L and Hatzigeorgiou AG: The DIANA-mirExTra web server: from gene expression data to microRNA function. PLoS One. 5:e91712010. View Article : Google Scholar : PubMed/NCBI
21	Kota J, Chivukula RR, O’Donnell KA, et al: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
22	Murakami Y, Yasuda T, Saigo K, et al: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar : PubMed/NCBI
23	Löbrich M and Jeggo PA: The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer. 7:861–869. 2007.PubMed/NCBI
24	Spitz DR, Azzam EI, Li JJ and Gius D: Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev. 23:311–322. 2004. View Article : Google Scholar
25	Luo H, Zou J, Dong Z, Zeng Q, Wu D and Liu L: Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. Biochem J. 442:311–321. 2012. View Article : Google Scholar : PubMed/NCBI
26	Creevey L, Ryan J, Harvey H, Bray IM, Meehan M, Khan AR and Stallings RL: MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1. Mol Cancer. 12:232013. View Article : Google Scholar : PubMed/NCBI
27	Meng F, Henson R, Lang M, et al: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
28	Varnholt H: The role of microRNAs in primary liver cancer. Ann Hepat. 7:104–113. 2008.
29	He L, He XY, Lowe SW and Hannon GJ: microRNAs join the p53 network--another piece in the tumour-suppression puzzle. Nat Rev Cancer. 7:819–822. 2007. View Article : Google Scholar : PubMed/NCBI
30	Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S and Miyazono K: Modulation of microRNA processing by p53. Nature. 460:529–533. 2009. View Article : Google Scholar : PubMed/NCBI
31	Rossi JJ: New hope for a microRNA therapy for liver cancer. Cell. 137:990–992. 2009. View Article : Google Scholar : PubMed/NCBI